Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cagent Vascular logo — Restoring Blood Flow. Restoring Life. Serranator: Serrate &...

Cagent Vascular

Restoring Blood Flow. Restoring Life. Serranator: Serrate & Inflate

Founded 2014 United States Wayne, United States 54 employees Series C Total: $51.87M Health Care, Medical Devices

General Information

Company Name Cagent Vascular
Founded Year 2014
Location United States Wayne, United States
Founders / Decision Makers
Team member Team member
Employees 54
Industries Health Care, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Cagent Vascular. To contact Cagent Vascular, visit cagentvascular.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Cagent Vascular

Cagent Vascular, based in Wayne, PA, is a medical devices company founded in 2014 with a focus on restoring blood flow and thereby restoring life. The company's flagship product, the Serranator PTA Serration Balloon Catheter, incorporates Serration Technology to address blockages in the leg caused by conditions such as Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia (CLTI). Cagent Vascular recently secured a significant $30.00M Series C investment on 20 February 2024 with backing from prominent investors such as US Venture Partners, Sectoral Asset Management, and Blue Ridge Medical. This injection of funds is expected to further propel the company's growth and enable it to advance its innovative solutions in the health care space. With its unique positioning as the first and only provider of an angioplasty balloon with serration technology, Cagent Vascular is well-positioned to make a significant impact in addressing critical arterial blockages. As the company continues to make strides in the medical devices sector and attract substantial investment, it will be crucial to monitor its progress and the adoption of its pioneering technology within the healthcare industry.

Taxonomy: Serranator, angioplasty balloon, serration technology, cardiovascular disease treatment, Peripheral Artery Disease (PAD), Chronic Limb Threatening Ischemia (CLTI), Cagent Vascular, blocked arteries treatment, innovative medical technology, vascular health, minimally invasive procedure, arterial disease, endovascular treatment, arterial blockages, leg artery treatment

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $30.00M 3
US Venture Partners Sectoral Asset Management Blue Ridge Medical
US Venture Partners, Sectoral Asset Management +1
20 Feb 2024
Venture Round $9.50M -
23 Jun 2021
Series B $11.87M 3
Ben Franklin Technology Partners Synergy Ventures
Ben Franklin Technology Partners, Synergy Ventures +1
12 Jul 2018
Seed Round $500.00K 1
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania
22 Jun 2016

Cagent Vascular Alternatives & Competitors

View All Alternatives
Cagent Vascular vs
Intact Vascular
Intact Vascular United States

Founded in 2011, Intact Vascular located in Wayne, PA is a privately held medical device company tha...

Debt Financing
6 employees
Health Care, Manufacturing
Compare Cagent Vascular vs Intact Vascular
Cagent Vascular vs
Ra Medical Systems
Ra Medical Systems United States

Our Mission: Save lives, limbs and improve patients’ quality of life.

Post-IPO Equity
36 employees
Health Care, Medical Devices
Cagent Vascular vs
R3 Vascular Inc.
R3 Vascular Inc. United States

The Next Generation of BTK Interventional Therapies for PAD

Series B
18 employees
Health Care, Manufacturing
Also compare with: Cagent Vascular vs Contego Medical, Inc. Contego Medical, Inc. View all alternatives

FAQ About Cagent Vascular

Restoring Blood Flow. Restoring Life. Serranator: Serrate & Inflate
Cagent Vascular was founded in 2014.
Cagent Vascular is headquartered in Wayne, United States.
Cagent Vascular operates in Health Care and Medical Devices. Its work centres on Serranator, angioplasty balloon, serration technology and cardiovascular disease treatment.
Cagent Vascular has approximately 54 employees.
Cagent Vascular has completed 4 funding rounds, raising a total of $51.87M. The latest funding stage is Series C.
Top alternatives and competitors to Cagent Vascular include Intact Vascular, Ra Medical Systems, R3 Vascular Inc., Vessix Vascular, Roxwood Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cagent Vascular and Intact Vascular are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cagent Vascular, https://bouncewatch.com/company/cagent-vascular, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes